Phenomics Australia’s in vitro node the Monash Organoid Program is hosting a free symposium on Emerging Technologies in Organoid Research at Monash University at Clayton, on 6 November 2024.
We are honoured to announce the participation of Prof Karuna Ganesh (Memorial Sloan Kettering Cancer Center, NYC) as the Keynote speaker. For its 4th edition, the Symposium will have a poster session with prizes to win (one for PhD students and one for ECRs).
You can find all the details about the event on the registration page, including the program and instructions to submit an abstract for poster presentation on the link below:
https://www.eventbrite.com.au/e/emerging-technologies-in-organoid-research-tickets-987538092017
Enquiries to Eglantine.Balland@monash.edu
For more information see the links below:
Another successful Organoid Symposium at Monash for this 2023 edition
Monash BDI Organoid Program Symposium 2022: A Resounding Success
Phenomics Australia provides a national centre of expertise and service provision to deploy a more comprehensive and sophisticated range of in vitro Genome Engineering and Disease Modelling capabilities to understand the functional consequences of DNA sequence variation in the human genome for health and disease while maintaining the expertise for in vivo disease modelling and genome engineering. To meet the high demand for adaptable and scalable disease-modelling platforms for improved diagnosis, Precision Medicine for genetic disorders, and therapeutic development by both academia and the biopharmaceutical industry, Phenomics Australia offers In Vitro services through a collaborative consortium of ten laboratories and facilities across Australia, operating at ANU (ANU Centre for Therapeutic Discovery), Perkins (Translational Cancer Research Program in Oncology), Monash (Monash Organoid Program & Monash Genome Modification Platform), MCRI (iPSC derivation & Gene Editing Facility), Peter Mac (Victorian Centre for Functional Genomics), UMelb (Centre for Stem Cell Systems & Stem Cell Disease Modelling Laboratory), UQ (In vitro Genome Engineering and Disease Modelling Service), and VCCRI (Stem Cell Production Facility iPSC Reprogramming Service)